Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma
- 27 November 2019
- journal article
- research article
- Published by Elsevier BV in Pathology
- Vol. 52 (1), 142-153
- https://doi.org/10.1016/j.pathol.2019.10.003
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (HA6145/3-1)
This publication has 86 references indexed in Scilit:
- Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?PLOS ONE, 2013
- Nodular lymphocyte predominant Hodgkin lymphoma with non‐invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcomeAmerican Journal of Hematology, 2012
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte‐predominant Hodgkin lymphomaBritish Journal of Haematology, 2012
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaHaematologica, 2011
- Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphomaBlood, 2011
- Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphomaHaematologica, 2010
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaThe New England Journal of Medicine, 2010
- T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune responseHaematologica, 2009
- Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysisThe Journal of Experimental Medicine, 2008
- Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6Blood, 2007